Elevated levels of homocysteine increase IL-6 production in monocytic Mono Mac 6 cells

Blood Coagulation and Fibrinolysis

Volumn 11, Issue 2, 2000, Pages 159-164

  Van Aken, B E ^b   Jansen, J ^b   Van Deventer, S J H ^b   Reitsma, P H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Cytokines; Homocysteine; Mono Mac 6

Indexed keywords

CYSTEINE; ENDOTOXIN; HOMOCYSTEINE; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; METHIONINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; ATHEROSCLEROSIS; CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HYPERHOMOCYSTEINEMIA; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS;

EID: 0008840296     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200011020-00007     Document Type: Article

References (25)

1. 1. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-1057.
2. 2. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49: 31-62.
3. 3. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood 1997; 90: 1-11.
4. 4. Wilcken DE, Wang XL, Wilcken B. Methylenetetrahydrofolate reductase (MTHFR) mutation, homocyst(e)ine, and coronary artery disease. Circulation 1997; 96: 2738-2740.
5. 5. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 1996; 94: 2410-2416.
6. 6. Mudd SH, Levy HL, Skovby WS. Disorders of transsulfuration. In: Scriver CR, Beadet AL, Sly WS (editors): The metabolic basis of inherited disease. New York, NY: McGraw-Hill; 1989. pp. 693-734.
7. 7. Lentz SR. Homocysteine and vascular dysfunction. Life Sci 1997; 61: 1205-1215.
8. 8. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338: 1042-1050.
9. 9. Blom HJ, Van der Molen EF. Pathobiochemical implications of hyperhomocysteinemia. Fibrinolysis 1994; 8: 86-87.
10. 10. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
11. 11. Dosquet C, Weill D, Wautier J. Cytokines and thrombosis. J Cardiovasc Pharmacol 1995; 25: S13-S19.
12. 12. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-126.
13. 13. Ziegler-Heitbrock HW, Thiel E, Futterer A, Herzog V, Wirtz A, Riethmuller G. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer 1988; 41: 456-461.
14. 14. Sturk A, Joop K, ten Cate JW, Thomas LL. Optimalization of a chromogenic assay for endotoxin in blood. Prog Clin Biol Res 1985; 189: 117-137.
15. 15. Todd RFD, Nadler LM, Schlossman SF. Antigens on human monocytes identified by monoclonal antibodies. J Immunol 1981; 126: 1435-1442.
16. 16. Erl W, Weber C, Wardemann C, Weber PC. Adhesion properties of Mono Mac 6, a monocytic cell line with characteristics of mature human monocytes. Atherosclerosis 1995; 113: 99-107.
17. 17. Duerre JA, Miller CH. Preparation of L-homocysteine from L-homocysteine thiolactone. Anal Biochem 1966; 17: 310-315.
18. 18. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-82.
19. 19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
20. 20. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today 1990; 11: 443-449.
21. 21. Ikeda U, Ikeda M, Oohara T, Oguchi A, Kamitani T, Tsuruya Y, et al. Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol 1991; 260: H1713-H1717.
22. 22. Watson C, Whittaker S, Smith N, Vora AJ, Dumonde DC, Brown KA. IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clin Exp Immunol 1996; 105: 112-119.
23. 23. Stouthard JM, Levi M, Hack CE, Veenhof CH, Romijn HA, Sauerwein HP, et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 1996; 76: 738-742.
24. 24. Ueland PM. Homocysteine species as components of plasma redox thiol status. Clin Chem 1995; 41: 340-342.
25. 25. Dalton ML, Gadson PF Jr, Wrenn RW, Rosenquist TH. Homocysteine signal cascade: production of phospholipids, activation of protein kinase C, and the induction of c-fos and c-myb in smooth muscle cells. FASEB J 1997; 11: 703-711.